There Is Only One Sure Way to Fix the Hepatitis C Epidemic

Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis

TIME

Save America’s Patent System

The New York Times

The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.

Filter

There Is Only One Sure Way to Fix the Hepatitis C Epidemic

Newsweek

Seven Days

Nature

Nonprofit challenges Gilead’s patents on sofosbuvir

Healio

Nonprofit Group I-MAK Files IPR Petitions Seeking to Invalidate Hepatitis C Drug Patent

Knobbe Martens

Trending News Today: Gilead HCV Drug Patents Challenged

Specialty Pharmacy Times

Gilead’s Lucrative Hep C Patents Face PTAB Assault

Law360

Gilead faces challenge to U.S. hepatitis C patents from advocacy group

STAT

Consumer group challenges Gilead patents on hepatitis C drug

Reuters

Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group

Bloomberg

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Intellectual Property Watch

Learn more about how you can help build a more equitable system for all